Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 May 2025 | Story Prof Mikateko Mathebula | Photo Supplied
Africa Month Alliance
Pictured (from left to right): Prof Faith Mkwananzi, Dr Kapambwe Mwelwa, Prof Lochner Marais, Prof Chikumbutso Manthalu, and Prof Mikateko Mathebula.

Through collaborative agreements with the University of Malawi and the University of Zambia, the University of the Free State (UFS) has established the Research Alliance for Higher Education in Africa (RAHEdA), a dynamic initiative aimed at enhancing research capacity and partnerships within Sub-Saharan Africa.

The initiative forms part of the UFS’s SARChI Chair in Higher Education and Human Development (HEHD) research programme. 

The collaborative agreements align with the UFS’s Vision 130 strategy in relation to internationalisation, emphasising the important role that intra-African mobility visits play in establishing relationships with universities on the continent. It also fosters knowledge exchange and engagement and allows for careful planning and strategy meetings. 

In 2024, the HEHD hosted Dr Kapambwe Mwelwa, a lecturer in the University of Zambia’s Department of Educational Administration and Policy Studies, and Prof Chikumbutso Manthalu, Head of Higher Education and Professional Development in the University of Malawi’s School of Education, for such a visit. Their engagements included research seminars, a PhD presentation day, and collaborative strategy sessions with UFS academics, including Prof Faith Mkwananzi and Prof Mikateko Mathebula from the UFS’s Centre for Development Support (CDS), who are co-founders of RAHEdA.

“During these discussions, an ambitious but feasible roadmap was laid out for the next three to five years,” Prof Mkwananzi said. “These activities include online workshops for staff and postgraduate students at all partner institutions, and a new webinar series that focuses on profiling, advancing, and celebrating thought leaders, higher education scholars, and scholarship in Africa.” 

The inaugural webinar was held on 21 May 2025. Speaker Prof Siseko Kumalo, Associate Professor at the University of Johannesburg’s Ali Mazrui Centre for Higher Education Studies, spoke on ‘Orality as the Bulwark of the Humanities?’, set the bar high for the webinar series through his compelling and original response to this timely question, as scholars around the world contemplate appropriate responses to the rise and influence of artificial intelligence in higher education teaching, learning, and assessment.

Funding to support RAHEdA has been generously provided by Prof Melanie Walker, Distinguished Professor and SARChI Chair in Higher Education and Human Development.

• For information on how to get involved and for updates on RAHEdA, please contact Prof Mikateko Mathebula at MathebulaM@ufs.ac.za

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept